5-hydroxymethyldeoxycytidine monophosphate has been researched along with Sarcoma, Myeloid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Fu, C; Jia, J; Jiang, Y; Liu, S; Pan, Y; Shi, Y; Tao, Y; Xiao, D; Zhou, J; Zhou, W | 1 |
1 other study(ies) available for 5-hydroxymethyldeoxycytidine monophosphate and Sarcoma, Myeloid
| Article | Year |
|---|---|
Decrease of TET2 expression and increase of 5-hmC levels in myeloid sarcomas.
Topics: 5-Methylcytosine; Adult; Antigens, CD; Antigens, CD34; Antigens, Differentiation, Myelomonocytic; Biomarkers, Tumor; Deoxycytidine; Dioxygenases; DNA-Binding Proteins; Female; Formaldehyde; Granulocyte Colony-Stimulating Factor; Humans; Immunohistochemistry; Interleukin-3; Male; Middle Aged; Paraffin Embedding; Proto-Oncogene Proteins; Recombinant Fusion Proteins; Sarcoma, Myeloid; Tissue Fixation; Young Adult | 2016 |